Feier Feng
Peking University(CN)Peking University Cancer Hospital(CN)Ministry of Education(ET)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Hematopoietic Stem Cell Transplantation, Lymphoma Diagnosis and Treatment, Mesenchymal stem cell research, Blood groups and transfusion
Most-Cited Works
- → Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression(2016)87 cited
- → Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades(2020)66 cited
- → Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model(2014)61 cited
- → Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF‐κB/SMAD pathway in patients with immune thrombocytopenia(2018)57 cited
- → Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling Pathway(2017)49 cited
- → Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial(2017)